BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 1807155)

  • 1. A chemiluminescent assay for quantitation of beta-galactosidase in the femtogram range: application to quantitation of beta-galactosidase in lacZ-transfected cells.
    Jain VK; Magrath IT
    Anal Biochem; 1991 Nov; 199(1):119-24. PubMed ID: 1807155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta galactosidase release as an alternative to chromium release in cytotoxic T-cell assays.
    Bachy M; Bonnin-Rivalland A; Tilliet V; Trannoy E
    J Immunol Methods; 1999 Nov; 230(1-2):37-46. PubMed ID: 10594352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of beta-galactosidase from yeast cells using a chemiluminescent substrate.
    Nevels M; Wolf H; Dobner T
    Biotechniques; 1999 Jan; 26(1):57-8. PubMed ID: 9894592
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemiluminescent assay of beta-D-galactosidase based on indole luminescence.
    Arakawa H; Tsuji A; Maeda M
    J Biolumin Chemilumin; 1998; 13(6):349-54. PubMed ID: 9926362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential suppression of background mammalian lysosomal beta-galactosidase increases the detection sensitivity of LacZ-marked leukemic cells.
    Hendrikx PJ; Martens AC; Visser JW; Hagenbeek A
    Anal Biochem; 1994 Nov; 222(2):456-60. PubMed ID: 7864372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual luminescence-based reporter gene assay for luciferase and beta-galactosidase.
    Martin CS; Wight PA; Dobretsova A; Bronstein I
    Biotechniques; 1996 Sep; 21(3):520-4. PubMed ID: 8879594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scanning assay of beta-galactosidase activity.
    Li W; Zhao X; Zou S; Ma Y; Zhang K; Zhang M
    Prikl Biokhim Mikrobiol; 2012; 48(6):668-72. PubMed ID: 23330395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A sensitive method for the detection of beta-galactosidase in transfected mammalian cells.
    Eustice DC; Feldman PA; Colberg-Poley AM; Buckery RM; Neubauer RH
    Biotechniques; 1991 Dec; 11(6):739-40, 742-3. PubMed ID: 1809326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-galactosidase assay.
    Smale ST
    Cold Spring Harb Protoc; 2010 May; 2010(5):pdb.prot5423. PubMed ID: 20439410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliable transient promoter assay using fluorescein-di-beta-D-galactopyranoside substrate.
    Ikenaka K; Fujino I; Morita N; Iwasaki Y; Miura M; Kagawa T; Nakahira K; Mikoshiba K
    DNA Cell Biol; 1990 May; 9(4):279-86. PubMed ID: 1693513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of beta-galactosidase activity in tissue in the presence of blood.
    Pelisek J; Armeanu S; Nikol S
    J Vasc Res; 2000; 37(6):585-93. PubMed ID: 11146413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verapamil inhibition of enzymatic product efflux leads to improved detection of beta-galactosidase activity in lacZ-transfected cells.
    Poot M; Arttamangkul S
    Cytometry; 1997 May; 28(1):36-41. PubMed ID: 9136753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An improved CPRG colorimetric ligand-receptor signal transduction assay based on beta-galactosidase activity in mammalian BWZ-reporter cells.
    Jendresen C; Daws MR; Nilsson LNG
    J Pharmacol Toxicol Methods; 2018; 90():67-75. PubMed ID: 29203451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comments on Methods to Suppress Endogenous β-Galactosidase Activity in Mouse Tissues Expressing the LacZ Reporter Gene.
    Merkwitz C; Blaschuk O; Schulz A; Ricken AM
    J Histochem Cytochem; 2016 Oct; 64(10):579-86. PubMed ID: 27555495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochemical observation of regulated bacterial beta-galactosidase gene expression in mammalian cells.
    Liu HS; Feliciano ES; Stambrook PJ
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):9951-5. PubMed ID: 2481319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rapid and simple chemiluminescent assay for Escherichia coli beta-galactosidase.
    Beale EG; Deeb EA; Handley RS; Akhavan-Tafti H; Schaap AP
    Biotechniques; 1992 Mar; 12(3):320-3. PubMed ID: 1571136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemiluminescent enzyme immunoassay for alpha-fetoprotein using beta-D-galactosidase as label and 5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside as substrate.
    Arakawa H; Ikegami T; Maeda M; Tsuji A
    J Biolumin Chemilumin; 1993; 8(3):135-9. PubMed ID: 7684183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An optimized method for the chemiluminescent detection of alkaline phosphatase levels during osteodifferentiation by bone morphogenetic protein 2.
    Blum JS; Li RH; Mikos AG; Barry MA
    J Cell Biochem; 2001; 80(4):532-7. PubMed ID: 11169737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escherichia coli beta-galactosidase as an in vitro and in vivo reporter enzyme and stable transfection marker in the intracellular protozoan parasite Toxoplasma gondii.
    Seeber F; Boothroyd JC
    Gene; 1996 Feb; 169(1):39-45. PubMed ID: 8635747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel NMR approach to assessing gene transfection: 4-fluoro-2-nitrophenyl-beta-D-galactopyranoside as a prototype reporter molecule for beta-galactosidase.
    Cui W; Otten P; Li Y; Koeneman KS; Yu J; Mason RP
    Magn Reson Med; 2004 Mar; 51(3):616-20. PubMed ID: 15004806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.